These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 27097724)

  • 21. The nitrate reductase assay for the rapid detection of isoniazid and rifampicin resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis.
    Martin A; Panaiotov S; Portaels F; Hoffner S; Palomino JC; Angeby K
    J Antimicrob Chemother; 2008 Jul; 62(1):56-64. PubMed ID: 18407918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of Mycobacterium tuberculosis cross-resistance to isoniazid, rifampicin and levofloxacin with their respective structural analogs.
    Imperiale BR; Di Giulio ÁB; Adrián Cataldi A; Morcillo NS
    J Antibiot (Tokyo); 2014 Nov; 67(11):749-54. PubMed ID: 24894185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapid genotypic assays to identify drug-resistant Mycobacterium tuberculosis in South Africa.
    Evans J; Stead MC; Nicol MP; Segal H
    J Antimicrob Chemother; 2009 Jan; 63(1):11-6. PubMed ID: 18940875
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro activity of (-)-deoxypergularinine, on its own and in combination with anti-tubercular drugs, against resistant strains of Mycobacterium tuberculosis.
    Nam KW; Jang WS; Jyoti MA; Kim S; Lee BE; Song HY
    Phytomedicine; 2016 May; 23(5):578-82. PubMed ID: 27064017
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular characterization of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis strains isolated in Kazakhstan.
    Kozhamkulov U; Akhmetova A; Rakhimova S; Belova E; Alenova A; Bismilda V; Chingissova L; Ismailov S; Ramanculov E; Momynaliev K
    Jpn J Infect Dis; 2011; 64(3):253-5. PubMed ID: 21617314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancement of drug susceptibility of multi-drug resistant strains of Mycobacterium tuberculosis by ethambutol and dimethyl sulphoxide.
    Jagannath C; Reddy VM; Gangadharam PR
    J Antimicrob Chemother; 1995 Mar; 35(3):381-90. PubMed ID: 7782254
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutant prevention concentration of isoniazid, rifampicin and rifabutin against Mycobacterium tuberculosis.
    Rodríguez JC; Cebrián L; Ruiz M; López M; Royo G
    Chemotherapy; 2005 May; 51(2-3):76-9. PubMed ID: 15870500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resistance to rifampicin and isoniazid in strains of Mycobacterium tuberculosis.
    Siddiqi SH; Aziz A; Reggiardo Z; Middlebrook G
    J Clin Pathol; 1981 Aug; 34(8):927-9. PubMed ID: 6792243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of rifampicin and isoniazid resistances of Mycobacterium tuberculosis strains by particle counting immunoassay (PACIA).
    Drowart A; Cambiaso CL; Huygen K; Serruys E; Portaels F; Jann E; Van Vooren JP
    Int J Tuberc Lung Dis; 1997 Jun; 1(3):284-8. PubMed ID: 9432378
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of Direct Colorimetric MTT Assay for Rapid Detection of Rifampicin and Isoniazid Resistance in Mycobacterium tuberculosis.
    Hundie GB; Woldemeskel D; Gessesse A
    PLoS One; 2016; 11(12):e0169188. PubMed ID: 28030634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current status of multidrug resistant tuberculosis in a tertiary care hospital of East Delhi.
    Sagar T; Singh NP; Kashyap B; Kaur IR
    J Postgrad Med; 2013; 59(3):173-6. PubMed ID: 24029192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence of cross resistance between rifampicin and rifabutin in Mycobacterium tuberculosis strains in Izmir, Turkey.
    Senol G; Erbaycu A; Ozsöz A
    J Chemother; 2005 Aug; 17(4):380-4. PubMed ID: 16167516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular characterization of mutation associated with rifampicin and isoniazid resistance in Mycobacterium tuberculosis isolates.
    Negi SS; Anand R; Pasha ST; Gupta S; Basir SF; Khare S; Lal S
    Indian J Exp Biol; 2006 Jul; 44(7):547-53. PubMed ID: 16872043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancement of in vitro activity of tuberculosis drugs by addition of thioridazine is not reflected by improved in vivo therapeutic efficacy.
    de Knegt GJ; ten Kate MT; van Soolingen D; Aarnoutse R; Boeree MJ; Bakker-Woudenberg IA; de Steenwinkel JE
    Tuberculosis (Edinb); 2014 Dec; 94(6):701-7. PubMed ID: 25621361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. M. tuberculosis genotypic diversity and drug susceptibility pattern in HIV-infected and non-HIV-infected patients in northern Tanzania.
    Kibiki GS; Mulder B; Dolmans WM; de Beer JL; Boeree M; Sam N; van Soolingen D; Sola C; van der Zanden AG
    BMC Microbiol; 2007 May; 7():51. PubMed ID: 17540031
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analytical and clinical performance characteristics of the Abbott RealTime MTB RIF/INH Resistance, an assay for the detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis in pulmonary specimens.
    Kostera J; Leckie G; Tang N; Lampinen J; Szostak M; Abravaya K; Wang H
    Tuberculosis (Edinb); 2016 Dec; 101():137-143. PubMed ID: 27865383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The predominance of Ethiopian specific Mycobacterium tuberculosis families and minimal contribution of Mycobacterium bovis in tuberculous lymphadenitis patients in Southwest Ethiopia.
    Tadesse M; Abebe G; Bekele A; Bezabih M; de Rijk P; Meehan CJ; de Jong BC; Rigouts L
    Infect Genet Evol; 2017 Nov; 55():251-259. PubMed ID: 28919549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Whole genome analysis of an MDR Beijing/W strain of Mycobacterium tuberculosis with large genomic deletions associated with resistance to isoniazid.
    Zhang Q; Wan B; Zhou A; Ni J; Xu Z; Li S; Tao J; Yao Y
    Gene; 2016 May; 582(2):128-36. PubMed ID: 26854371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms of heteroresistance to isoniazid and rifampin of Mycobacterium tuberculosis in Tashkent, Uzbekistan.
    Hofmann-Thiel S; van Ingen J; Feldmann K; Turaev L; Uzakova GT; Murmusaeva G; van Soolingen D; Hoffmann H
    Eur Respir J; 2009 Feb; 33(2):368-74. PubMed ID: 18829680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid direct detection of multiple rifampin and isoniazid resistance mutations in Mycobacterium tuberculosis in respiratory samples by real-time PCR.
    Marín M; García de Viedma D; Ruíz-Serrano MJ; Bouza E
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4293-300. PubMed ID: 15504855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.